Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?

The DoP has asked the health ministry and drug regulatory authority to
monitor if hospitals are prescribing the high-priced remdesivir where
low-priced antibiotics would do, as it has received complaints of
indiscriminate prescription of remdesivir by big hospitals, even in
cases where it was not needed.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/are-hospitals-prescribing-the-more-expensive-remdesivir-instead-of-cheaper-alternatives/articleshow/77135780.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment